Table 3.
Study | Type of study | Study size | Prolapse grade | Stapler device | Follow-up (mo) | Primary outcome |
---|---|---|---|---|---|---|
Reboa et al. [247] (2016) | Multicenter, retrospective | 621 | 3, 4 | CPH34 HVa | 12 | Residual hemorrhoidal prolapse, 1.8% |
Recurrent hemorrhoidal prolapse, 1.9% | ||||||
Wei et al. [248] (2022) | Single-center, retrospective | 125 | 3 | TST STARR Plusb | 57.3c | Recurrence rate, 5.2% |
Sturiale et al. [236] (2023) | Single-center, retrospective | 59 | 2–4 | TST STARR Plusb | 70.5c | Recurrence rate, 5.1% |
Frankenman International Ltd.
Touchstone International Medical Science Co Ltd.
Median.